Maplight Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.93

+0.71 (+11.41%)

As of Nov 7, 10:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 85%

Hold 3 15%

Sell 0 0%

Price Target

Analyst Price Target +811.8% upside

Low Target $44.21

Average Target $63.19

High Target $83.67

Current Price $6.93

Current
$6.93

Target
$63.19

$44.21 $63.19 avg $83.67

Scenario Analysis

Bear Case

$44.21

538.0%

Low target

Base Case

$63.19

+811.8%

Avg target

Bull Case

$83.67

+1,107.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$40.43

-82.9% from high

52-Week Low

$6.19

+12.0% from low

Target vs 52W High

$63.19

+56.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	32%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-40.7%